Ronald Hunt, Director, 10% Owner at Iterum Therapeutics plc (ITRM), bought 1,129,470 shares at $13.00 ($8.6M) on 2018-05-30, disclosed to the SEC on 2018-05-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 466,793 | $0 | 0.0% |
| 2 | $13.00 | 278,062 | $3.6M | 42.0% |
| 3 | $13.00 | 384,615 | $5.0M | 58.0% |
| Total | $7.63 avg | 1,129,470 | $8.6M | 100% |
| Filing → |
| HARP | BUY | 2019-02-14 | $6.0M | — | Filing → |
| MEIP | SELL | 2014-12-10 | $476K | — | Filing → |
| RLYP | BUY | 2013-11-20 | $2.0M | — | Filing → |